Multi-spectral spatially modulated light is used to guide localized spectroscopy of surgically resected tissues for cancer involvement. Modulated imaging rapidly quantifies near-infrared optical parameters with sub-millimeter resolution over the entire field for identification of residual disease in resected tissues. Suspicious lesions are further evaluated using a spectroscopy platform designed to image thick tissue samples at a spatial resolution sensitive to the diagnostic gold standard, pathology. MI employs a spatial frequency domain sampling and model-based analysis of the spatial modulation transfer function to interpret a tissue's absorption and scattering parameters at depth. The spectroscopy platform employs a scanning-beam, telecentric dark-field illumination and confocal detection to image fields up to 1cm 2 with a broadband source (480:750nm). The sampling spot size (100µm lateral resolution) confines the volume of tissue probed to within a few transport pathlengths so that multiple-scattering effects are minimized and simple empirical models may be used to analyze spectra. Localized spectroscopy of Intralipid and hemoglobin phantoms demonstrate insensitivity of recovered scattering parameters to changes in absorption, but a non-linear dependence of scattering power on Intralipid concentration is observed due to the phase sensitivity of the measurement system. Both systems were validated independently in phantom and murine studies. Ongoing work focuses on assessing the combined utility of these systems to identify cancer involvement in vitro, particularly in the margins of resected breast tumors.
INTRODUCTION
Breast conserving therapy (BCT), which includes local excision and radiation treatment to the breast, has been the standard of care for early breast cancers (Stage 0-II), since five major prospective, randomized trials in North American and Europe demonstrated that the long-term survival after BCT is equivalent to that of radical mastectomy for most patients when surgical margins are clear of residual disease [1] [2] [3] [4] [5] . Most of the 250,000 women annually diagnosed with breast cancer are eligible for BCT, resulting in approximately 165,000-180,000 conservative surgeries each year 6 . Following breast conservation, the strongest risk factor for local recurrence and mortality is a positive resection margin (tumor cells on ink). Therefore, if a margin is positive or close (cancer present within 1-2mm of margin surface), the patient is advised to undergo re-excision surgery to achieve clear margins 7, 8 . Margin status is currently evaluated postoperatively by microscopic evaluation of pathology in small, representative pieces of tissue. While sampled tissues are adequate for assessing tumor type, grade and receptor status, they are insufficient for evaluating important prognostic factors like disease extent, multi-focality and heterogeneity.
The fundamental challenge encountered when applying spectral techniques to margin assessment is the need for microscopic resolution over a wide field. Techniques that probe large volumes of tissue rely on the assumption that ultra-structural malignant transformations provide disease-specific contrast in volume-averaged measures, but breast tissue is markedly heterogeneous, which makes distinguishing small foci of cancer within the spectrum of normal tissue challenging [9] [10] [11] . Most spectral tools developed for margin assessment involve fiber bundles that cannot sample the full tissue field at a resolution sufficient to account for specimen heterogeneity 12, 13 . So while spectroscopy methods like fluorescence, diffuse reflectance and Raman spectroscopy are responsive to the tissue's biochemical and ultra-structural state [14] [15] [16] [17] [18] ; these techniques minimally sample tissue pathology.
A broadband spectroscopy platform was developed to image thick tissue samples at a resolution sensitive to the diagnostic gold standard, pathology 19 . Tissue samples were raster-scanned across a static beam using a motorized stage and the sampling spot size (100µm lateral resolution) confined the volume of tissue probed to within a few transport pathlengths so that multiple-scattering effects were minimized and simple empirical models parameterized the spectra. A k-Nearest Neighbor (k-NN) classifier was trained using parameters extracted from the localized scattering spectrum, automating diagnosis of benign and malignant breast pathologies in situ with a sensitivity and specificity of 91% and 77% respectively. Performance of the classifier was validated in 67,000 spectra from 29 excised breast tissues 20 . This initial study characterized the spectral response of breast pathologies, but the system's utility was limited by its long data acquisition times and restricted sampling field.
Data acquisition times have been improved via development of a dark-field in situ scanning-beam spectroscopy platform that rapidly sample fields up to 1cm 2 . Nonetheless, candidates for BCT may have tumors up to 5cm in diameter and spectral analysis of the full tumor field is not feasible. To overcome the fundamental tradeoff between microscopic resolution and field side, a multi-modal approach was employed. Modulated imaging (MI), a non-contact and nonscanning technique that rapidly samples wide-field optical properties at sub-millimeter resolution, was used to guide dense spectral sampling using the scanning-beam spectroscopy platform 21 . Scanned ROI are then correlated with pathology to validate the combine utility of these tools to assess tumor margin status. Figure (1) presents a schematic of this methodology. 
METHODOLOGY

Multi-spectral spatially modulated light to guide spectroscopy
Modulated imaging (MI) employs spatial frequency domain sampling and model-based analysis of the spatial modulation transfer function (s-MTF) to interpret a tissue's optical properties at depth. A compact modulated imaging system was purchased from Modulated Imaging Inc., to map a tissue's absorption and scattering parameters at depth using spatially modulated plane wave projections in the NIR (658, 730, 850, 970nm). System specifications and theory are detailed in the references 22, 23 .
Sinusoidal patterns of varying spatial frequency are projected onto the sample using a projection system and digital micro-mirror device. A one-dimensional modulation is generated in the x-direction to simplify the homogenous model of diffuse reflectance and a 16-bit CCD camera captures the diffusely reflected photons. Specular reflections are minimized by illuminating at a small angle to normal incidence and by using crossed linear polarizers. Each spatial frequency is projected at three phase angles for amplitude demodulation of the AC and DC signals 24 . A Siloxane TiO 2 reflectance standard is used to calibrate for intensity fluctuations and spatial non-uniformity in the illumination and imaging systems. Each spatial frequency projection is repeated at four NIR wavelengths using high power LED sources (658, 730, 850 and 970nm) and interference filters are employed to constrain the detection waveband. Diffuse reflectance is mapped as a function of frequency using the spatial Fourier transform of modulated images obtained at varying spatial frequencies. The steady state diffusion equation reduces to a second-order Helmholtz equation for fluence as a function of depth when assuming a sinusoidal source incident upon a homogenous, linear media 22 . Multi-spectral measures allow the use of a power law modified by Beer's law to fit for the reduced scattering coefficient and chromophore concentrations. The near-infrared wavelengths enable quantification of the concentrations of oxygenated and deoxygenated hemoglobin, water, adipose and cellular scattering. Optical properties are recovered using a rapid twofrequency look up table (LUT), constructed using cubic spline interpolation of the forward-model data at two frequencies.
Scanning-beam broadband spectroscopy in suspicious ROI
Suspicious lesions identified by MI parameter maps are imaged at a higher resolution using the scanning-beam spectroscopy platform. Its illumination and detection spot size is laterally constrained to 100μm, minimizing multiplescattering effects so that simple empirical models may be used to parameterize the spectra. Full spectra are acquired at each 100μm-diameter pixel for thick tissue samples in a 1cm 2 field. The spectroscopy platform is detailed in the reference 21 . It combines a broadband telecentric scanning design with dark-field illumination/detection for efficient rejection of specular light, while maintaining a consistent sampling geometry across the image field. A tungsten halogen lamp is used as the source (480:750nm) with an exposure time of 300ms for pancreas tissues. Tissue acquisition took approximately 40min, during which time the tissue was hydrated with phosphate buffer saline. Much faster exposure times are possible with a broadband super continuum laser source, which is currently being integrated into the system. All measures are background subtracted and referenced to gray Spectralon (Labsphere Inc) on a point-by-point basis. An empirical approximation to Mie theory modified by a Beer-Lambert attenuation factor to account for local absorption by chromophores was sufficient to parameterize spectra 20 .
Here, the wavelength-dependence of the reduced scattering coefficient is described by a combination of Rayleigh and Mie theory. A, b and f are the scattering amplitude, scattering power, and Mie contribution to scatter respectively.
The scattered reflectance is exponentially attenuated due to chromophore absorption. The absorption coefficient is defined as the product of each chromophore concentration with its wavelength-dependent molar extinction coefficient. The primary tissue absorbers in the 480-750nm waveband are oxygenated and deoxygenated hemoglobin. Their concentrations are coupled by the parameters: total hemoglobin, [HbT] and the oxygen saturation factor, fSO 2 . The molar extinction spectra of these chromophores are given by ε HbO 2 (λ) and ε Hb (λ) respectively 25 . Γ λ represents the mean optical pathlengths, which depends on both the measurement geometry and the absorption and scattering properties of the tissue. Scanned ROI are then correlated with the diagnostic gold standard, pathology, to assess the ability of these tools to assess the tissue's disease state.
DATA
Phantom Data
A series of Intralipid and hemoglobin phantoms were imaged to characterize the spectroscopy system's response to changes in absorption and scattering. A series of scattering phantoms with [5 4 3 2 1 0.5] % Intralipid were serially diluted with porcine blood, with a maximum concentration of 30uM hemoglobin. All measures were background subtracted and referenced to 5% Intralipid on a point-by-point basis. The exposure time was 100ms. Figure 2(a) shows the nonlinear relationship between the calculated 26 and recovered reduced scattering coefficient for varying concentrations of hemoglobin. Recovered scattering parameters are independent to changes in absorption, but a nonlinear dependence on scatterer concentration is observed due to the phase sensitivity of the measurement system. Figure 2(b) shows the recovered product of total hemoglobin concentration and transport path length, as a function of true hemoglobin concentration, at the five concentrations of Intralipid. The box and whisker plots illustrate the spread in recovered absorption parameter for all concentrations of Intralipid. Similarly, phantom studies are being used to characterize the spectral response of the modulated imaging system.
Tissue Data
To assess the combined use of modulated imaging and the scanning beam spectroscopy platform to characterize the pathology of excised tissues, four normal pancreas and four pancreas tumors mouse were imaged in a murine model in vitro. The tissue was hydrated with a phosphate buffer solution and imaged immediately after excision. Figure 3 (a-c) shows the optical maps of a murine pancreas on a diffusive background generated by modulated imaging. A suspicious region of interest is highlighted in blue. Figure 3(d) shows the parameter maps generated by the scanning-beam spectroscopy platform within the suspicious field of view and Figure 3 (e) shows its corresponding pathology. Optical maps were correlated to pathology and the spectral response of normal, tumor and necrotic pathologies were assessed. Correlation with microscopic features was not possible because the histopatholopic processing of the murine tissues resulted in severe artifacts that limited co-registration between pathology and recovered optical maps. In the future, inked pins will be used to mark imaged fields of view to improve co-registration.
RESULTS
Figure 4(a) shows the spectral response of normal, tumor and necrotic tissue in the murine pancreas. Greater scattering slope is observed in the tumor and necrotic pathologies as compared to normal pathologies. Figure 4(b-d) illustrates clustering of the spectral remission parameters for all pixels according to pathologic diagnosis. This type of dataset may be used to train a classification algorithm to identify pathologies based spectral features, as demonstrated previously using breast tissues 20 . Only the scattering power distribution was normal as determined by looking at the normal data probability plot for all parameters and diagnostic categories. Normality is expected to improve with increasing sample size. A Kruskal-Wallis test was used to compare the medians for each parameter distribution according to diagnostic category. Figure 5(a-d) illustrates box plots of each parameter distribution according to diagnosis. The computed p-values were all much less than 0.05, indicating that the sample medians are significantly different.
CONCLUSIONS
Breast tissue is markedly heterogeneous, therefore wide field of view imaging is necessary to assess disease extent. Additionally, localized spectroscopy is needed to identify small foci of cancer within a heterogeneous background and to correlate measures with the diagnostic gold standard, pathology. The proposed methodology uses NIR spatially modulated light to guide localized spectroscopy of excised tissues. The modulated imaging system samples the full tissue field, rapidly, in a non-contact and non-scanning way. The scanning-beam spectroscopy platform rapidly rasterscans thick tissue samples in 1cm 2 suspicious fields of view, recovering broadband spectra from each 100-micron diameter pixel. The systems have been validated independently and this multi-modal methodology was assessed in murine studies. Future work involves assessment of the combined utility of the systems identify residual cancer in resected breast tissues.
